BIMZELX vs RESTASIS

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 17, 2026·How we rate

Possible drug interaction. BIMZELX and RESTASIS are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	BIMZELX	RESTASIS
Rating	70/100	72/100
Pharmacy pays	—	~$52.85 /30
Type	RX	RX
Active ingredient	BIMEKIZUMAB-BKZX	CYCLOSPORINE
Manufacturer	Ucb Inc	Allergan
Dosage forms	Injectable	Emulsion
Drug class	—	Calcineurin Inhibitor Immunosuppressant
Boxed warning	None	None
Half-life	—	about 8.4 hours (range 5 to 18 hours)
Treats	Psoriasis	Rheumatoid Arthritis, Focal Segmental Glomerulosclerosis, Systemic Lupus Erythematosus

bimzelx restasis

Rating

70/100

72/100

Pharmacy pays

—

~$52.85 /30

Type

Active ingredient

BIMEKIZUMAB-BKZX

CYCLOSPORINE

Manufacturer

Ucb Inc

Allergan

Dosage forms

Injectable

Emulsion

Drug class

—

Calcineurin Inhibitor Immunosuppressant

Boxed warning

None

Half-life

—

about 8.4 hours (range 5 to 18 hours)

Treats

Psoriasis

Rheumatoid Arthritis, Focal Segmental Glomerulosclerosis, Systemic Lupus Erythematosus

Frequently asked questions

Which is better-rated, Bimzelx or Restasis?

By our independent rating, Restasis scores higher — 3.6 vs 3.5 out of 5 for Bimzelx. Ratings are based on FDA regulatory (recall-safety) data.

What is the difference between Bimzelx and Restasis?

Bimzelx contains Bimekizumab-Bkzx, while Restasis contains Cyclosporine — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.